New contract manufacturer buys plant
KBI BioPharma, a start-up biopharma contract manufacturer, has signed an agreement to buy a facility in North Carolina that could be online in 6-9 months.
Archives for August 7, 2003
Caliper sheds jobs after Zymark buy
Caliper has cut 9 per cent of its staff as part of a restructuring exercise following its $72 million acquisition of lab automation company Zymark.
Cambrex sells non-core business
Cambrex plans to sell off its Rutherford Chemicals business for $64 million (€56m) to allow it to focus on its human health and biosciences activities.
Bayer sales on the slide in second quarter
Bayer has reported a decline in net profits for the second quarter of 2003, with analysts expressing concerns that litigations costs could hold back full-year earnings.
BASF sees no recovery until fourth quarter
BASF, the world's largest chemicals company, has said that it will expand an ongoing restructuring program in North America after reporting lower-than-expected second-quarter sales and profits.
New player Hikal offers gabapentin
India's Hikal has entered into an agreement with an unnamed US-based pharmaceutical company to supply gabapentin, set to lose its patent protection.